col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


58 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Molecular Psychiatry
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2025―Jan―15 Choroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes Maria Diez-Cirarda, Miguel Yus-Fuertes, Cristina Delgado-Alonso, Lidia Gil-Martínez, Carlos Jiménez-García, Maria José Gil-Moreno, Natividad Gómez-Ruiz, Silvia Oliver-Mas, Carmen Polidura, Manuela Jorquera, Ulises Gómez-Pinedo, Juan Arrazola, Silvia Sánchez-Ramón, Jorge Matias-Guiu, Gabriel Gonzalez-Escamilla, Jordi A. Matias-Guiu
2 [GO] 2024―Nov―09 Maternal COVID-19 infection associated with offspring neurodevelopmental disorders Lian Duan, Huamin Yin, Jiaxin Liu, Wenhang Wang, Peijun Huang, Li Liu, Jingling Shen, Zhendong Wang
3 [GO] 2024―Oct―30 Investigating the impact of severe maternal SARS-CoV-2 infection on infant DNA methylation and neurodevelopment Rachel A. Hill, Andrew Gibbons, Wittaya Suwakulsiri, Angela Taseska, Hayley Darke, Atul Malhotra, Hnin Yee, Michael Fahey, Rod W. Hunt, Izaak Lim, Kirsten Palmer, Suresh Sundram
4 [GO] 2024―Sep―16 Acute COVID-19 severity markers predict post-COVID new-onset psychiatric disorders: A 2-year cohort study of 34,489 patients Matthieu Gasnier, Pierre Pinson, Nathanael Beeker, Camille Truong-Allié, Laurent Becquemont, Bruno Falissard, Emmanuelle Corruble, Romain Colle
5 [GO] 2024―Jul―03 Genetic analyses point to alterations in immune-related pathways underpinning the association between psychiatric disorders and COVID-19 Anna Monistrol-Mula, Santiago Diaz-Torres, Mireia Felez-Nobrega, Josep Maria Haro, Sarah E. Medland, Brittany L. Mitchell
6 [GO] 2024―Jun―21 Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 Guangting Zeng, Jianqiang Li, Linlin Wang, Zanling Zhang
7 [GO] 2024―Jun―04 Psychiatric adverse events following COVID-19 vaccination: a population-based cohort study in Seoul, South Korea Hong Jin Kim, Min-Ho Kim, Myeong Geun Choi, Eun Mi Chun
8 [GO] 2024―Apr―27 Long COVID: plasma levels of neurofilament light chain in mild COVID-19 patients with neurocognitive symptoms Elisa Gouvea Gutman, Andreza Lemos Salvio, Renan Amphilophio Fernandes, Larissa Araujo Duarte, Jessica Vasques Raposo-Vedovi, Helena França Alcaraz, Milene Ataíde Teixeira, Giselle Fazzioni Passos, Karoline Queiroz Muniz de Medeiros, Mariana Beiral Hammerle, Karina Lebeis Pires, Claudia Cristina Ferreira Vasconcelos, Luciane Almeida Amado Leon, Cláudia Pinto Figueiredo, Soniza Vieira Alves-Leon
9 [GO] 2024―Jan―18 Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020-2022 Christina X. Wang, Rhea Kohli, Veronica R. Olaker, Pauline Terebuh, Rong Xu, David C. Kaelber, Pamela B. Davis
10 [GO] 2023―Dec―19 Composite healthy lifestyle, socioeconomic deprivation, and mental well-being during the COVID-19 pandemic: a prospective analysis Gang Hu, Huibo Qin, Binbin Su, Yanping Bao, Zhengting Liang, Yunhe Wang
11 [GO] 2023―Aug―03 The risk of hospitalization for psychotic disorders following hospitalization for COVID-19: a French nationwide longitudinal study Baptiste Pignon, Valentina Decio, Philippe Pirard, Olivier Bouaziz, Emmanuelle Corruble, Pierre A. Geoffroy, Viviane Kovess-Masfety, Marion Leboyer, Cédric Lemogne, Jonathan Messika, Vittorio Perduca, Franck Schürhoff, Nolwenn Regnault, Sarah Tebeka
12 [GO] 2023―Jul―25 Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update Sizhen Su, Yimiao Zhao, Na Zeng, Xiaoxing Liu, Yongbo Zheng, Jie Sun, Yi Zhong, Shuilin Wu, Shuyu Ni, Yimiao Gong, Zhibo Zhang, Nan Gao, Kai Yuan, Wei Yan, Le Shi, Arun V. Ravindran, Thomas Kosten, Jie Shi, Yanping Bao, Lin Lu
13 [GO] 2023―Jul―19 Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: a prospective population-based cohort study Joane Matta, Olivier Robineau, Emmanuel Wiernik, Fabrice Carrat, Gianluca Severi, Mathilde Touvier, Clément Gouraud, Charles Ouazana Vedrines, Victor Pitron, Brigitte Ranque, Baptiste Pignon, Nicolas Hoertel, Sofiane Kab, Marcel Goldberg, Marie Zins, Cédric Lemogne
14 [GO] 2023―Jul―04 Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein-Barr virus and the gut-brain axis Kenji Hashimoto
15 [GO] 2023―Apr―17 The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study Katharina Schultebraucks, Wivine Blekic, Cale Basaraba, Tom Corbeil, Zain Khan, Brandy F. Henry, Noa Krawczyk, Bianca D. Rivera, Bennett Allen, Caroline Arout, Harold Alan Pincus, Diana M. Martinez, Frances R. Levin
16 [GO] 2023―Mar―03 Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study Bruce J. Kirenga, Levicatus Mugenyi, Marina Sánchez-Rico, Henry Kyobe, Winters Muttamba, Raymond Mugume, Eliya Mwesigwa, Ezra Kalimo, Vicky Nyombi, Ivan Segawa, Loryndah Olive Namakula, Rogers Sekibira, Wilberforce Kabweru, Rosemary Byanyima, Hellen Aanyu, Pauline Byakika-Kibwika, Henry G. Mwebesa, Nicolas Hoertel, William Bazeyo
17 [GO] 2023―Jan―23 The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China Yimiao Zhao, Le Shi, Zhendong Jiang, Na Zeng, Huan Mei, Yu Lu, Jinfeng Yang, Fenshu Jin, Shuyu Ni, Shuilin Wu, Sizhen Su, Yongbo Zheng, Kai Yuan, Wei Yan, Siwei Sun, Shiqiu Meng, Jie Sun, Zunera Khan, Dag Aarsland, Jie Shi, Xiangyou Li, Yanping Bao, Lin Lu
18 [GO] 2022―Dec―23 When 1 + 1 = 3: the COVID-19 and addiction syndemic Gavin Bart
19 [GO] 2022―Dec―13 Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US Lindsey Wang, Nora D. Volkow, Nathan A. Berger, Pamela B. Davis, David C. Kaelber, Rong Xu
20 [GO] 2022―Dec―06 Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022 Jonas J. de Paula, Fabio L. S. Duran, Geraldo Busatto, Debora M. Miranda, Marco A. Romano-Silva
21 [GO] 2022―Nov―01 SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, Sandra Parker, Xaria X. Li, Danushka K. Wijesundara, Julio Aguado, Adriana Pliego Zamora, Christopher L. D. McMillan, Benjamin Liang, Nias Y. G. Peng, Julian D. J. Sng, Fatema Tuj Saima, Jenny N. Fung, John D. Lee, Devina Paramitha, Rhys Parry, Michael S. Avumegah, Ariel Isaacs, Martin W. Lo, Zaray Miranda-Chacon, Daniella Bradshaw, Constanza Salinas-Rebolledo, Niwanthi W. Rajapakse, Ernst J. Wolvetang, Trent P. Munro, Alejandro Rojas-Fernandez, Paul R. Young, Katryn J. Stacey, Alexander A. Khromykh, Keith J. Chappell, Daniel Watterson, Trent M. Woodruff
22 [GO] 2022―Oct―07 Impact of the COVID-19 pandemic on non-COVID-19 hospital mortality in patients with schizophrenia: a nationwide population-based cohort study Laurent Boyer, Guillaume Fond, Vanessa Pauly, Veronica Orléans, Pascal Auquier, Marco Solmi, Christoph U. Correll, Dong Keon Yon, Pierre-Michel Llorca, Karine Baumstarck-Barrau, Antoine Duclos
23 [GO] 2022―Oct―05 Neurogenesis is disrupted in human hippocampal progenitor cells upon exposure to serum samples from hospitalized COVID-19 patients with neurological symptoms Alessandra Borsini, Blair Merrick, Jonathan Edgeworth, Gargi Mandal, Deepak P. Srivastava, Anthony C. Vernon, Gaia Nebbia, Sandrine Thuret, Carmine M. Pariante
24 [GO] 2022―Oct―05 The relationship of adverse childhood experiences, hair cortisol, C-reactive protein, and polygenic susceptibility with older adults’ psychological distress during the COVID-19 pandemic Katie S. Taylor, Andrew Steptoe, Eleonora Iob
25 [GO] 2022―Oct―05 SARS-CoV-2 promotes microglial synapse elimination in human brain organoids Ana O. Oliveira, Susmita Malwade, Nuno Rufino de Sousa, Sravan K. Goparaju, Jessica Gracias, Funda Orhan, Laura Steponaviciute, Martin Schalling, Steven D. Sheridan, Roy H. Perlis, Antonio G. Rothfuchs, Carl M. Sellgren
26 [GO] 2022―Sep―19 Predominance of visuoconstructive impairment after mild COVID-19? María Díez-Cirarda, Miguel Yus, Jorge Matías-Guiu, Jordi A. Matias-Guiu
27 [GO] 2022―Jun―15 Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems Victor M. Castro, Jonathan Rosand, Joseph T. Giacino, Thomas H. McCoy, Roy H. Perlis
28 [GO] 2022―Jun―14 Selective visuoconstructional impairment following mild COVID-19 with inflammatory and neuroimaging correlation findings Jonas Jardim de Paula, Rachel E. R. P. Paiva, Nathália Gualberto Souza-Silva, Daniela Valadão Rosa, Fabio Luis de Souza Duran, Roney Santos Coimbra, Danielle de Souza Costa, Pedro Robles Dutenhefner, Henrique Soares Dutra Oliveira, Sarah Teixeira Camargos, Herika Martins Mendes Vasconcelos, Nara de Oliveira Carvalho, Juliana Batista da Silva, Marina Bicalho Silveira, Carlos Malamut, Derick Matheus Oliveira, Luiz Carlos Molinari, Danilo Bretas de Oliveira, José Nélio Januário, Luciana Costa Silva, Luiz Armando De Marco, Dulciene Maria de Magalhaes Queiroz, Wagner Meira, Geraldo Busatto, Débora Marques Miranda, Marco Aurélio Romano-Silva
29 [GO] 2022―Jun―06 A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action Kai Yuan, Yong-Bo Zheng, Yi-Jie Wang, Yan-Kun Sun, Yi-Miao Gong, Yue-Tong Huang, Xuan Chen, Xiao-Xing Liu, Yi Zhong, Si-Zhen Su, Nan Gao, Yi-Long Lu, Zhe Wang, Wei-Jian Liu, Jian-Yu Que, Ying-Bo Yang, An-Yi Zhang, Meng-Ni Jing, Chen-Wei Yuan, Na Zeng, Michael V Vitiello, Vikram Patel, Seena Fazel, Harry Minas, Graham Thornicroft, Teng-Teng Fan, Xiao Lin, Wei Yan, Le Shi, Jie Shi, Thomas Kosten, Yan-Ping Bao, Lin Lu
30 [GO] 2022―Jun―06 A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action Na Zeng, Yi-Miao Zhao, Wei Yan, Chao Li, Qing-Dong Lu, Lin Liu, Shu-Yu Ni, Huan Mei, Kai Yuan, Le Shi, Peng Li, Teng-Teng Fan, Jun-Liang Yuan, Michael V Vitiello, Thomas Kosten, Alexandra L Kondratiuk, Hong-Qiang Sun, Xiang-Dong Tang, Mei-Yan Liu, Ajit Lalvani, Jie Shi, Yan-Ping Bao, Lin Lu
31 [GO] 2022―Apr―22 COVID-19 and severe mental illness in Israel: testing, infection, hospitalization, mortality and vaccination rates in a countrywide study Nehama Goldberger, Tal Bergman-Levy, Ziona Haklai, Rinat Yoffe, Michael Davidson, Ehud Susser, Linda Levi, Tal Elhasid, Mark Weiser
32 [GO] 2022―Apr―06 Comments to “Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists” by Khani and Entezari-Maleki Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
33 [GO] 2022―Apr―06 Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists Elnaz Khani, Taher Entezari-Maleki
34 [GO] 2022―Feb―08 The 90 plus: longevity and COVID-19 survival Mayana Zatz, Monize V. R. Silva, Mateus V. de Castro, Michel S. Naslavsky
35 [GO] 2022―Jan―21 Implications of parental stress on worsening of behavioral problems in children with autism during COVID-19 pandemic: “the spillover hypothesis” Adrien A. Eshraghi, Leylane Cavalcante, Emily Furar, Michael Alessandri, Rebecca S. Eshraghi, F. Daniel Armstrong, Rahul Mittal
36 [GO] 2022―Jan―12 In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach Michael Maes, Walton Luiz Del Tedesco Junior, Marcell Alysson Batisti Lozovoy, Mayara Tiemi Enokida Mori, Tiago Danelli, Elaine Regina Delicato de Almeida, Alexandre Mestre Tejo, Zuleica Naomi Tano, Edna Maria Vissoci Reiche, Andréa Name Colado Simão
37 [GO] 2022―Jan―07 Mechanisms of action of fluvoxamine for COVID-19: a historical review Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
38 [GO] 2021―Dec―07 Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of the UK Biobank Lamiece Hassan, Niels Peek, Karina Lovell, Andre F. Carvalho, Marco Solmi, Brendon Stubbs, Joseph Firth
39 [GO] 2021―Nov―26 Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatients Nicolas Hoertel, Marina Sánchez-Rico, Juan José Herrera-Morueco, Pedro de la Muela, Erich Gulbins, Johannes Kornhuber, Alexander Carpinteiro, Katrin Anne Becker, Céline Cougoule, Frédéric Limosin
40 [GO] 2021―Oct―04 The acid sphingomyelinase/ceramide system in COVID-19 Johannes Kornhuber, Nicolas Hoertel, Erich Gulbins
41 [GO] 2021―Sep―27 A systematic review and meta-analysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action Kai Yuan, Xiao-Lin Huang, Wei Yan, Yu-Xin Zhang, Yi-Miao Gong, Si-Zhen Su, Yue-Tong Huang, Yi Zhong, Yi-Jie Wang, Ze Yuan, Shan-Shan Tian, Yong-Bo Zheng, Teng-Teng Fan, Ying-Jian Zhang, Shi-Qiu Meng, Yan-Kun Sun, Xiao Lin, Tian-Ming Zhang, Mao-Sheng Ran, Samuel-Yeung-Shan Wong, Nicolas Rüsch, Le Shi, Yan-Ping Bao, Lin Lu
42 [GO] 2021―Aug―12 Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms Nicolas Hoertel, Marina Sánchez-Rico, Céline Cougoule, Erich Gulbins, Johannes Kornhuber, Alexander Carpinteiro, Katrin Anne Becker, Angela M. Reiersen, Eric J. Lenze, David Seftel, Cédric Lemogne, Frédéric Limosin
43 [GO] 2021―Aug―04 Stress-related emotional and behavioural impact following the first COVID-19 outbreak peak Asaf Benjamin, Yael Kuperman, Noa Eren, Ron Rotkopf, Maya Amitai, Hagai Rossman, Smadar Shilo, Tomer Meir, Ayya Keshet, Orit Nuttman-Shwartz, Eran Segal, Alon Chen
44 [GO] 2021―Jul―20 Post-traumatic stress symptoms in COVID-19 survivors: a self-report and brain imaging follow-up study Yiheng Tu, Yuqi Zhang, Yu Li, Qing Zhao, Yanzhi Bi, Xuejing Lu, Yazhuo Kong, Li Wang, Zhijie Lu, Li Hu
45 [GO] 2021―Jul―19 Can antidepressants unlock prescription of rimonabant in the fight against COVID-19? Juliette Salles, Fabienne Briand-Mésange, Stéphanie Trudel, Jérôme Ausseil, Jean-Pierre Salles, Hugues Chap
46 [GO] 2021―Feb―17 Mechanisms for substance use disorders in COVID-19 Zhicheng Lin
47 [GO] 2021―Feb―04 Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study Nicolas Hoertel, Marina Sánchez-Rico, Raphaël Vernet, Nathanaël Beeker, Anne-Sophie Jannot, Antoine Neuraz, Elisa Salamanca, Nicolas Paris, Christel Daniel, Alexandre Gramfort, Guillaume Lemaitre, Mélodie Bernaux, Ali Bellamine, Cédric Lemogne, Guillaume Airagnes, Anita Burgun, Frédéric Limosin
48 [GO] 2021―Feb―04 Prevalence of posttraumatic stress disorder after infectious disease pandemics in the twenty-first century, including COVID-19: a meta-analysis and systematic review Kai Yuan, Yi-Miao Gong, Lin Liu, Yan-Kun Sun, Shan-Shan Tian, Yi-Jie Wang, Yi Zhong, An-Yi Zhang, Si-Zhen Su, Xiao-Xing Liu, Yu-Xin Zhang, Xiao Lin, Le Shi, Wei Yan, Seena Fazel, Michael V. Vitiello, Richard A. Bryant, Xin-Yu Zhou, Mao-Sheng Ran, Yan-Ping Bao, Jie Shi, Lin Lu
49 [GO] 2021―Jan―22 The impact of quarantine on mental health status among general population in China during the COVID-19 pandemic Yunhe Wang, Le Shi, Jianyu Que, Qingdong Lu, Lin Liu, Zhengan Lu, Yingying Xu, Jiajia Liu, Yankun Sun, Shiqiu Meng, Kai Yuan, Maosheng Ran, Lin Lu, Yanping Bao, Jie Shi
50 [GO] 2020―Dec―16 Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology Deidiane Elisa Ribeiro, Ágatha Oliveira-Giacomelli, Talita Glaser, Vanessa F. Arnaud-Sampaio, Roberta Andrejew, Luiz Dieckmann, Juliana Baranova, Claudiana Lameu, Mariusz Z. Ratajczak, Henning Ulrich
51 [GO] 2020―Dec―14 Social media and smartphone app use predicts maintenance of physical activity during Covid-19 enforced isolation in psychiatric outpatients Agnes Norbury, Shelley H. Liu, Juan José Campaña-Montes, Lorena Romero-Medrano, María Luisa Barrigón, Emma Smith, Antonio Artés-Rodríguez, Enrique Baca-García, M. Mercedes Perez-Rodriguez
52 [GO] 2020―Sep―30 Correction: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States Quan Qiu Wang, David C. Kaelber, Rong Xu, Nora D. Volkow
53 [GO] 2020―Sep―14 Changes in network centrality of psychopathology symptoms between the COVID-19 outbreak and after peak Yuanyuan Wang, Zhishan Hu, Yi Feng, Amanda Wilson, Runsen Chen
54 [GO] 2020―Sep―14 COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States Quan Qiu Wang, David C. Kaelber, Rong Xu, Nora D. Volkow
55 [GO] 2020―Sep―01 The COVID-19 pandemic and epidemiologic insights from recession-related suicide mortality Tarun Bastiampillai, Stephen Allison, Jeffrey C. L. Looi, Julio Licinio, Ma-Li Wong, Seth W. Perry
56 [GO] 2020―Aug―10 A paradox of social distancing for SARS-CoV-2: loneliness and heightened immunological risk Liron Rozenkrantz, Michael H. Bernstein, Christopher C. Hemond
57 [GO] 2020―Jul―28 Molecular Psychiatry, August 2020: new impact factor, and highlights of recent advances in psychiatry, including an overview of the brain’s response to stress during infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Julio Licinio, Ma-Li Wong
58 [GO] 2020―May―07 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis Charlotte Steenblock, Vladimir Todorov, Waldemar Kanczkowski, Graeme Eisenhofer, Andreas Schedl, Ma-Li Wong, Julio Licinio, Michael Bauer, Allan H. Young, Raul R. Gainetdinov, Stefan R. Bornstein
 [1] 

58 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec